NYSE · Medical - Healthcare Plans

CI (CI) Stock

$283.06 +2.53% NYSE: CI Healthcare

Valuation

MetricValue
Price$283.06
Market Cap$74.80B
P/E Ratio11.58
P/B Ratio1.74
P/S Ratio0.26
EPS (TTM)$0.00
52-Week High$315.47
52-Week Low$239.51
Dividend Yield2.22%

Financials & Margins

MetricValue
ROE15.24%
ROA4.08%
ROCE9.61%
Gross Margin3.32%
Operating Margin3.32%
Net Margin2.27%
Debt/Equity0.75
Current Ratio0.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$174.1B$180.5B$195.3B$247.1B$275.0B
Operating Profit$7.9B$8.4B$8.5B$9.4B$9.1B
Net Profit$5.4B$6.7B$5.2B$3.4B$6.0B
EPS$15.75$21.41$17.39$12.12$22.17
Op Margin4.6%4.7%4.4%3.8%3.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$154.9B$143.9B$152.8B$155.9B$157.9B
Total Liabilities$107.7B$99.0B$106.4B$114.6B$116.0B
Cash$5.1B$5.9B$7.8B$7.5B$7.7B
Borrowings$34.3B$31.6B$30.9B$32.0B$31.5B

Latest News

UNH Showered Owners With Cash. The Stock Did Not Cooperate Trefis · Jul 10, 2026 What to Expect From Cigna's Next Quarterly Earnings Report Barchart · Jul 9, 2026 The Real Price Of UnitedHealth Stock Isn't On Today's Label Trefis · Jul 9, 2026 Bernstein Adjusts Price Target on Cigna Group to $381 From $371 MT Newswires · Jul 9, 2026 Bernstein Adjusts Price Target on Cigna to $381 From $371 MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$7.2B$8.7B$11.8B$10.4B$9.6B
Investing Cash Flow$-4.8B$1.8B$-6.7B$-3.5B$-5.6B
Financing Cash Flow$-7.9B$-7.7B$-2.8B$-7.4B$-4.3B
Net Cash Flow$-4.7B$428.0M$2.4B$594.0M$126.0M
Free Cash Flow$6.0B$7.4B$10.2B$9.0B$8.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.37
EV / EBITDA8.48
FCF Yield12.28%
Quick Ratio0.74
Interest Coverage7.00
Return 1Y-4.66%
Return 3Y4.83%
Return 5Y40.41%

Ownership

Insiders Held1.43%
Institutions Held92.65%
Institutions Float Held93.99%
Institutional HolderSharesReport Date
Blackrock Inc.22,598,1522026-03-31
Vanguard Capital Management LLC17,122,0692026-03-31
State Street Corporation12,283,1412026-03-31
Massachusetts Financial Services Co.11,595,1822026-03-31
Dodge & Cox Inc.11,555,7872026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDX $187.12 -0.53% 57.29 $51.56B 2.21%
CAH $239.35 +2.02% 32.79 $56.06B 0.86%
CNC $65.11 +1.20% -5.11 $32.16B 0.00%
COR $331.22 +2.35% 23.93 $64.44B 0.74%
CVS $97.60 +3.93% 24.63 $124.53B 2.82%

About CI

CI is led by CEO David Michael Cordani, employs 71,295 people, headquartered in Bloomfield, US, publicly traded since 1982.

CI stock trades at $283.06 with a market capitalization of $74.80B. The stock is valued at a price-to-earnings (P/E) ratio of 11.58, price-to-book of 1.74, price-to-sales of 0.26. Over the past 52 weeks the stock has ranged between $239.51 and $315.47, and currently trades 10.3% below its 52-week high. It pays a dividend yielding 2.22%.

On profitability, CI generates a return on equity (ROE) of 15.24%, above the typical market average, return on capital employed of 9.61%, an operating margin of 3.32%, a net profit margin of 2.27%.

In its most recent fiscal year, CI reported annual revenue of $275.0B, net profit of $6.0B, revenue has compounded at 11.4% a year over the last five years, profit at -6.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.75, a current ratio of 0.85, total assets of $157.9B, $7.7B in cash and equivalents.

CI has a beta of 0.32 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides